JM Sosenko, JP Palmer, CJ Greenbaum, J … - Diabetes Care, 2006 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—Fifty-four DPT-1 participants (22 in the
parenteral trial and 32 in the oral trial) were studied. All had oral glucose
tolerance tests (OGTTs) at 6-month intervals from approximately 30 to 6 ... Cited by 40 - Related articles - BL Direct - All 5 versions
[CITATION] Diabetes Study Group: Effects of oral insulin in relatives of patients with type 1 diabetes
P Xu, D Cuthbertson, C Greenbaum, JP Palmer … - Diabetes Care, 2007 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—Subjects (n = 186) who had a projected 25–50%
risk for diabetes and subjects (n = 170) who had a projected >50% risk for type
1 diabetes in 5 years were followed until clinical diabetes onset or the ... Cited by 15 - Related articles - BL Direct - All 5 versions
- ►diabetesjournals.org JM Sosenko, JP Palmer, CJ Greenbaum, J … - Diabetes care, 2007 - Am Diabetes Assoc RESULTS—ROC areas under the curve (ROCAUCs) for both the AUC glucose (0.73 ±
0.02) and an OGTT prediction index (0.78 ± 0.02) were higher (P < 0.001) than
those for the fasting (0.53 ± 0.02) and 2-h glucose (0.66 ± 0.02). ... Cited by 12 - Related articles - BL Direct - All 4 versions
- ►diabetesjournals.org NA Sherry, EB Tsai, KC Herold - Diabetes, 2005 - Am Diabetes Assoc Despite extensive and ongoing investigations of the immune mechanisms of
autoimmune diabetes in humans and animal models, there is much less information
about the natural history of insulin secretion before and after the ... Cited by 37 - Related articles - BL Direct - All 6 versions
CJ Greenbaum, D Cuthbertson, JP Krischer - Diabetes, 2001 - Am Diabetes Assoc The clinical presentation of type 1 diabetes usually involves symptoms such as
polyuria and polydipsia. However, investigators in the Diabetes Prevention Trial
of Type 1 Diabetes (DPT-1) have detected a group of subjects with type 1 ... Cited by 29 - Related articles - BL Direct - All 5 versions
MA Atkinson - Diabetes, 2005 - Am Diabetes Assoc Thirty years ago, a convergence of investigational ob- servations lead to the
now widely accepted notion that type 1 diabetes results from an autoimmune
destruction of insulin-producing -cells in subjects genetically pre- ... Cited by 28 - Related articles - All 3 versions
I Weets, I Truyen, I Verschraegen, B Van … - Diabetologia, 2006 - Springer Page 1. Diabetologia (2006) 49: 1158–1162 DOI 10.1007/s00125-006-0191-x SHORT
COMMUNICATION I. Weets . I. Truyen . I. Verschraegen . B. Van der Auwera . ... Cited by 10 - Related articles - BL Direct - All 3 versions
JS Skyler - Clinical Pharmacology & Therapeutics, 2007 - nature.com Type 1 diabetes mellitus (T1D) arises from selective immunologically mediated
destruction of the insulin-producing -cells in the pancreatic islets of
Langerhans with consequent insulin deficiency. 1, 2 This occurs in ... Cited by 33 - Related articles - All 4 versions
